"Interferon beta-1b" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS.
| Descriptor ID |
D000068576
|
| MeSH Number(s) |
D12.644.276.374.440.890.275.750 D12.776.467.374.440.890.275.750 D23.529.374.440.890.275.750
|
| Concept/Terms |
Interferon beta-1b- Interferon beta-1b
- beta-1b, Interferon
- Beta-IFN-1b
- Interferon Beta, Ser(17)
- Ser(17) IFN-beta
- Serine(17) Interferon Beta
- Interferon beta 1b
- 1b, Interferon beta
- beta 1b, Interferon
- IFN-Beta Ser
- Interferon Beta, Serine(17)
|
Below are MeSH descriptors whose meaning is more general than "Interferon beta-1b".
Below are MeSH descriptors whose meaning is more specific than "Interferon beta-1b".
This graph shows the total number of publications written about "Interferon beta-1b" by people in this website by year, and whether "Interferon beta-1b" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interferon beta-1b" by people in Profiles.
-
Becker RV, Dembek C. Effects of cohort selection on the results of cost-effectiveness analysis of disease-modifying drugs for relapsing-remitting multiple sclerosis. J Manag Care Pharm. 2011 Jun; 17(5):377-81.
-
Williams BJ, Skinner HJ, Maria BL. Increased intracranial pressure in a case of pediatric multiple sclerosis. J Child Neurol. 2008 Jun; 23(6):699-702.
-
Markovic-Plese S, Bielekova B, Kadom N, Leist TP, Martin R, Frank JA, McFarland HF. Longitudinal MRI study: the effects of azathioprine in MS patients refractory to interferon beta-1b. Neurology. 2003 Jun 10; 60(11):1849-51.
-
Richert ND, Ostuni JL, Bash CN, Leist TP, McFarland HF, Frank JA. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Mult Scler. 2001 Feb; 7(1):49-58.
-
Khan OA, Hebel JR. Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon beta-1b in patients with relapsing-remitting multiple sclerosis. Ann Neurol. 1998 Jul; 44(1):138-9.
-
Webster GF, Knobler RL, Lublin FD, Kramer EM, Hochman LR. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis. J Am Acad Dermatol. 1996 Feb; 34(2 Pt 2):365-7.